Status:
UNKNOWN
Pudendal Nerve Block With Bupivacaine Alone and Bupivacaine With Methylene Blue for Postoperative Analgesia
Lead Sponsor:
Nepal Mediciti Hospital
Conditions:
Hemorrhoids
Anal Fissure and Fistula
Eligibility:
All Genders
15-90 years
Phase:
NA
Brief Summary
Study Description: The goal of this clinical trial is to compare the duration of postoperative pain relief achieved with two different approaches to pudendal nerve block in patients undergoing electi...
Detailed Description
Study Description: The aim of this randomized comparative study is to investigate the effectiveness of two different approaches to postoperative analgesia in patients undergoing perianal surgery. The...
Eligibility Criteria
Inclusion
- All patients of ASA I and II undergoing elective perianal surgery under spinal anesthesia
Exclusion
- Patient's refusal
- Patient with a history of allergy to the local anesthetic or Methylene blue
- Bleeding diathesis or coagulopathy
- Extensive infection at the site of injection
- Pregnancy and lactating mother
- Spinal abnormality
- Patients with neurological deficit
Key Trial Info
Start Date :
August 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05990569
Start Date
August 12 2023
End Date
July 1 2024
Last Update
November 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nepal Mediciti Hospital
Lalitpur, Nepal, 44700